|Editor-in-Chief: Steven Lipshultz (USA)|
|Submit a Manuscript||Editorial Board||Author Instructions||Article Alerts|
Dear Prof CERASALE MORTEO,
We are pleased to announce that Cardio-Oncology has published its first articles. We hope these articles, and our journal launch podcast on Cardio-Oncology, are of interest and that you will consider submitting your manuscript to the journal.
|Inaugural articles & launch podcast|
An Invitation from the Editors of Cardio-Oncology
Steven E. Lipshultz, Giorgio Minotti, Joseph Carver, Vivian I. Franco
Cardiac Safety of Afatinib: A Review of Data From Clinical Trials
Michael S Ewer, Kalpesh Patel, Dennis O’Brien, Robert M Lorence
Effect of myocardial dysfunction in Cardiac Morbidity and All Cause Mortality in Childhood Cancer Subjects treated with Anthracycline Therapy
Olga H Toro-Salazar, Eileen Gillan, Joanna Ferranti, Andrea Orsey, et al.
Low Dose Radiation and Circulatory Diseases: A Brief Narrative Review
Mark P. Little, Steven E Lipshultz
Cardio-oncology, how cancer treatments affect the heart
|Journal aims & scope|
Cardio-Oncology aims to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment.
|Why publish with us?|
|Only journal dedicated to this emerging field|
|Expert international Editorial Board|
|Fast, high quality peer review service|
|Rapid publication upon acceptance|
|Highest possible global visibility for your research|
|About article-processing charges|
Learn more about article-processing charges (APC) and member institutions that cover all or part of the author APC.
|BioMed Central Ltd, 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom.|